Michigan Driver Education Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00340470|
Recruitment Status : Completed
First Posted : June 21, 2006
Last Update Posted : July 2, 2017
Teens are at high risk for traffic violations and car crashes because of their young age, lack of driving experience, and exposure to high-risk driving conditions. The Checkpoints Program has used increased parental restrictions on teen driving through at least the first 4 months after their children obtain a driver's permit.
The purpose of this study is to evaluate the efficacy of the Checkpoints Program.
Approximately 400 teens in Michigan will participate in one of two study groups. One group will take standard driver education classes; the other group will take driver education classes that incorporate the Checkpoints Program. Teens and their parents will complete a written survey after completing the classes and a telephone survey after teens obtain a driver's permit. Teens will complete additional telephone surveys 1, 3, 6, and 12 months after obtaining a driver's permit. Researchers will use this information to study how parents manage teen driving practices, teen driving experiences (amount and conditions of), and high-risk teen driving behaviors.
|Condition or disease||Intervention/treatment||Phase|
|Behavioral Intervention||Behavioral: Driver Education||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||0 participants|
|Official Title:||Michigan Young Drivers Intervention Study|
|Study Start Date :||July 24, 2003|
|Study Completion Date :||February 6, 2007|
- Adoption of the parent-teen driving agreement.
- Prent-imposed driving restrictions during the first 12 months of driving.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00340470
|United States, Michigan|
|University of Michigan|
|Ann Arbor, Michigan, United States, 48109-0624|